Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01X" (195)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Other Antineoplastic Agents (L01X) 9 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Nilotinib Spirig HC 150 mg
112
938.38
1036.95
10 %
Capsules: Nilotinibum 150 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Nilotinib Spirig HC 200 mg
28
430.64
484.75
10 %
Capsules: Nilotinibum 200 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Nilotinib Spirig HC 200 mg
112
1412.51
1552.60
10 %
Capsules: Nilotinibum 200 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Nintedanib Spirig HC 100 mg
60
795.50
873.45
10 %
Weichkapsel: Nintedanibum 100 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Nintedanib Spirig HC 150 mg
60
795.50
873.80
10 %
Weichkapsel: Nintedanibum 150 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Voranigo 10 mg
30
k.A.
Coated tablets: Vorasidenibum 10 mg
Servier (Suisse) SA
A
FB
G
IP
CI
Voranigo 40 mg
30
k.A.
Coated tablets: Vorasidenibum 40 mg
Servier (Suisse) SA
A
FB
G
IP
CI
Nilotinib Spirig HC 50 mg
120
k.A.
Capsules: Nilotinibum 50 mg
Spirig HealthCare AG
A
FB
G
Nilotinib Zentiva 150 mg
112
k.A.
Capsules: Nilotinibum 150 mg
Helvepharm AG
A
FB
G
Cisplatin (L01XA01) 12 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Cisplatin Accord 10 mg/10 ml
14.00
31.65
10 %
Concentrate for infusion: Cisplatinum 10mg / 10ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Cisplatin Accord 25 mg/25 ml
30.80
49.95
10 %
Concentrate for infusion: Cisplatinum 25mg / 25ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Cisplatin Accord 50 mg/50 ml
56.85
78.30
10 %
Concentrate for infusion: Cisplatinum 50mg / 50ml
Accord Healthcare AG
● 
A / SL / SG
FB
G
IP
Cisplatin Accord 100
mg/100 ml
97.70
122.85
10 %
Concentrate for infusion: Cisplatinum 100mg / 100ml
Accord Healthcare AG
● 
A / SL / SG
FB
G
IP
Cisplatin Sandoz 50
mg/100 ml
Durchstechflasche(n)
58.90
80.40
10 %
Concentrate for infusion: Cisplatinum 50mg / 100ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Cisplatin Sandoz 25 mg/50 ml
Durchstechflasche(n)
32.37
51.55
10 %
Concentrate for infusion: Cisplatinum 25mg / 50ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Cisplatin Sandoz 10 mg/20 ml
Durchstechflasche(n)
14.68
32.35
10 %
Concentrate for infusion: Cisplatinum 10mg / 20ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Cisplatin Sandoz 100
mg/100 ml
Durchstechflasche(n)
107.46
132.90
10 %
Concentrate for infusion: Cisplatinum 100mg / 100ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Cisplatin-Teva, 0.5 mg/ml
Durchstechflasche(n) à 10 mg
14.00
31.65
10 %
Concentrate for infusion: Cisplatinum
Teva Pharma AG
A / SL / SG
FB
G
IP
Cisplatin-Teva, 0.5 mg/ml
Durchstechflasche(n) à 50 mg
56.89
78.35
10 %
Concentrate for infusion: Cisplatinum
Teva Pharma AG
A / SL / SG
FB
G
IP
Cisplatin-Teva, 1 mg/ml
Durchstechflasche(n) à 100 mg
97.71
122.90
10 %
Concentrate for infusion: Cisplatinum 1 mg/ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Cisplatin-Teva, 0.5 mg/ml
Durchstechflasche(n) à 25 mg
14.00
38.75
k.A.
Concentrate for infusion: Cisplatinum
Teva Pharma AG
A
FB
G
Carboplatin (L01XA02) 24 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Paraplatin 150 mg/15 ml
Durchstechflasche(n) à 150 mg
26.45
45.15
10 %
Infusion solution: Carboplatinum 150mg / 15ml
Cheplapharm Schweiz
GmbH
A / SL / SO
FB
G
IP
Paraplatin 450 mg/45 ml
Durchstechflasche(n) à 450 mg
87.30
110.85
20 %
Infusion solution: Carboplatinum 450mg / 45ml
Cheplapharm Schweiz
GmbH
A / SL / SO
FB
G
IP
Carboplatin Accord 50
mg/5 ml
8.76
25.95
10 %
Infusion solution: Carboplatinum 50mg / 5ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Accord 150
mg/15 ml
26.45
45.15
10 %
Infusion solution: Carboplatinum 150mg / 15ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Accord 450
mg/45 ml
79.34
102.70
10 %
Infusion solution: Carboplatinum 450mg / 45ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Accord 600
mg/60 ml
105.79
131.35
10 %
Infusion solution: Carboplatinum 600mg / 60ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Labatec 150
mg/15 ml
Durchstechflasche(n)
26.45
45.15
10 %
Infusion solution: Carboplatinum 150mg / 15ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Carboplatin Labatec 450
mg/45 ml
Durchstechflasche(n)
79.37
102.75
10 %
Infusion solution: Carboplatinum 450mg / 45ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Carboplatin Labatec 600
mg/60 ml
Durchstechflasche(n)
105.83
131.35
10 %
Infusion solution: Carboplatinum 600mg / 60ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Carboplatin Labatec 50
mg/5 ml
Durchstechflasche(n)
8.76
25.95
10 %
Infusion solution: Carboplatinum 50mg / 5ml
Labatec Pharma SA
A / SL / SG
FB
G
IP
Carboplatin Sandoz 50
mg/5 ml
8.76
25.95
10 %
Infusion solution: Carboplatinum 50mg / 5ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Carboplatin Sandoz 150
mg/15 ml
26.45
45.15
10 %
Infusion solution: Carboplatinum 150mg / 15ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Carboplatin Sandoz 450
mg/45 ml
79.37
102.75
10 %
Infusion solution: Carboplatinum 450mg / 45ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Carboplatin Sandoz 600
mg/60 ml
105.83
131.35
10 %
Infusion solution: Carboplatinum 600mg / 60ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Carboplatin-Teva liquid 50 mg / 5 ml
7.97
25.10
10 %
Infusion solution: Carboplatinum 50mg / 5ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Carboplatin-Teva liquid 150 mg / 15 ml
24.05
42.70
10 %
Infusion solution: Carboplatinum 150mg / 15ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Carboplatin-Teva liquid 450 mg / 45 ml
79.37
102.75
10 %
Infusion solution: Carboplatinum 450mg / 45ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Carboplatin-Teva liquid 600 mg / 60 ml
96.46
121.75
10 %
Infusion solution: Carboplatinum 600mg / 60ml
Teva Pharma AG
● 
A / SL / SG
FB
G
IP
Carboplatin Sandoz 1000
mg/100 ml
k.A.
Infusion solution: Carboplatinum 1000mg / 100ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Carboplatin Sandoz 50
mg/5 ml
Durchstechflasche(n)
12.93
27.15
k.A.
Infusion solution: Carboplatinum 50mg / 5ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Carboplatin Sandoz 150
mg/15 ml
Durchstechflasche(n)
38.80
60.95
k.A.
Infusion solution: Carboplatinum 150mg / 15ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Carboplatin Sandoz 450
mg/45 ml
Durchstechflasche(n)
110.81
143.60
k.A.
Infusion solution: Carboplatinum 450mg / 45ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Carboplatin Sandoz 600
mg/60 ml
Durchstechflasche(n)
156.47
196.05
k.A.
Infusion solution: Carboplatinum 600mg / 60ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Carboplatin Sandoz 1000
mg/100 ml
Durchstechflasche(n)
256.50
310.85
k.A.
Infusion solution: Carboplatinum 1000mg / 100ml
Sandoz
Pharmaceuticals AG
A
FB
G
Elotuzumab (L01XC23) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
PP
Empliciti 300 mg
1002.54
1106.75
10 %
Lyophilisate: Elotuzumabum 300 mg
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
PP
Empliciti 400 mg
1336.72
1470.20
10 %
Lyophilisate: Elotuzumabum 400 mg
Bristol-Myers Squibb SA
A / SL
FB
G
Aminolevulinic Acid (L01XD04) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
Ameluz 78 mg/g
2 g
193.15
226.50
10 %
Gel: Acidum Aminolaevulinicum 78 mg
Louis Widmer AG
B / SL
FB
G
L
IP
CI
Alacare 2 mg/cm2
4 plaster(s)
120.00
146.90
10 %
wirkstoffhaltiges Pflaster: Aminolaevulinatis Hydrochloridum 10.2 mg
Gebro Pharma AG
B / SL
FB
G
L
IP
CI
Alacare 2 mg/cm2
8 plaster(s)
211.20
246.10
10 %
wirkstoffhaltiges Pflaster: Aminolaevulinatis Hydrochloridum 10.2 mg
Gebro Pharma AG
B / SL
FB
G
Imatinib (L01XE01) 6 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Imatinib Devatis 100 mg
(teilbar)
30
231.03
267.65
10 %
Coated tablets: Imatinibum 100 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 100 mg
(teilbar)
60
462.06
518.95
10 %
Coated tablets: Imatinibum 100 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 200 mg
30
430.55
484.65
10 %
Coated tablets: Imatinibum 200 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 200 mg
60
757.78
840.55
10 %
Coated tablets: Imatinibum 200 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 400 mg
30
923.22
1020.45
10 %
Coated tablets: Imatinibum 400 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 400 mg
60
1624.89
1783.60
10 %
Coated tablets: Imatinibum 400 mg
Devatis AG
A / SL / SG
FB
G
Everolimus (L01XE10) 7 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Afinitor 10 mg
30 Tablet(s)
1510.79
1640.90
10 %
Tablets: Everolimusum 10 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Votubia 2 mg
30 Tablet(s)
911.01
1007.20
10 %
Dispersible Tablets: Everolimusum 2 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 3 mg
30 Tablet(s)
1366.51
1502.60
10 %
Dispersible Tablets: Everolimusum 3 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 2.5 mg
30 Tablet(s)
1138.75
1254.85
10 %
Tablets: Everolimusum 2.5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 5 mg
30 Tablet(s)
2202.22
2411.45
10 %
Tablets: Everolimusum 5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Afinitor 5 mg
30
1049.49
1144.90
10 %
Tablets: Everolimusum 5 mg
Novartis Pharma
Schweiz AG
SO
FB
G
IP
CI
Afinitor 2.5 mg
30 Tablet(s)
k.A.
Tablets: Everolimusum 2.5 mg
Novartis Pharma
Schweiz AG
A
FB
G
Bortezomib (L01XG01) 12 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
Velcade 1 mg
Durchstechflasche(n)
148.27
176.30
10 %
Lyophilisate: Bortezomibum 1 mg
Janssen-Cilag AG
A / SL / SO
FB
G
L
IP
Velcade 3.5 mg
Durchstechflasche(n)
410.05
460.10
10 %
Lyophilisate: Bortezomibum 3.5 mg
Janssen-Cilag AG
A / SL / SO
FB
G
L
IP
Bortezomib Accord liquid 2.5
mg/1 ml
270.98
311.10
10 %
Injection solution: Bortezomibum 2.5 mg/ml
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Bortezomib Accord liquid 3.5
mg/1.4 ml
372.78
421.85
10 %
Injection solution: Bortezomibum 3.5mg / 1.4ml
Accord Healthcare AG
● 
A / SL / SG
FB
G
L
IP
Bortezomib liquid Spirig HC 3.5
mg/1.4 ml
372.78
421.85
10 %
Injection solution: Bortezomibum 3.5mg / 1.4ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Bortezomib liquid Spirig HC 7
mg/2.8 ml
641.18
713.75
10 %
Injection solution: Bortezomibum 7mg / 2.8ml
Spirig HealthCare AG
● 
A / SL / SG
FB
G
L
IP
Bortezomib Zentiva 1.0 mg
126.04
153.50
10 %
Lyophilisate: Bortezomibum 1 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Bortezomib Zentiva 3.5 mg
372.78
421.85
10 %
Lyophilisate: Bortezomibum 3.5 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Bortezomib Sandoz 1 mg
126.04
153.50
10 %
Dry substance: Bortezomibum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Bortezomib Sandoz 3.5 mg
372.78
421.85
10 %
Dry substance: Bortezomibum 3.5 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Bortezomib Accord 1 mg
126.04
153.50
10 %
Pulver zur Herstellung einer lnjektionslösung: Bortezomibum 1 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Bortezomib Accord 3.5 mg
372.78
421.85
10 %
Pulver zur Herstellung einer lnjektionslösung: Bortezomibum 3.5 mg
Accord Healthcare AG
A / SL / SG
FB
G
Carfilzomib (L01XG02) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
PP
Kyprolis 10 mg
170.85
202.25
10 %
Lyophilisate: Carfilzomibum 10 mg
Amgen Switzerland AG
A / SL
FB
G
L
IP
PP
Kyprolis 30 mg
512.54
573.85
10 %
Lyophilisate: Carfilzomibum 30 mg
Amgen Switzerland AG
A / SL
FB
G
L
IP
PP
Kyprolis 60 mg
Durchstechflasche(n)
1025.08
1131.25
10 %
Lyophilisate: Carfilzomibum 60 mg
Amgen Switzerland AG
A / SL
FB
G
Asparaginase (L01XX02) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Enrylaze 10 mg/vial
3
k.A.
Injection solution: Crisantaspasum 10mg / 0.5ml
MEDA Pharmaceuticals
Switzerland GmbH
A
FB
G
Hydroxycarbamide (L01XX05) 6 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Litalir
100 Capsule(s)
65.38
87.15
10 %
Capsules: Hydroxycarbamidum 500 mg
Cheplapharm Schweiz
GmbH
A / SL / SO
FB
G
IP
CI
Hydroxycarbamid Devatis 500 mg
100
59.44
81.05
10 %
Capsules: Hydroxycarbamidum 500 mg
Devatis AG
A / SL / SG
FB
G
IP
CI
Hydroxycarbamid Devatis 500 mg
100
59.44
81.05
10 %
Capsules: Hydroxycarbamidum 500 mg
Devatis AG
A / SL / SG
FB
G
IP
CI
Hydroxycarbamid Labatec 500 mg
50
29.72
48.75
10 %
Capsules: Hydroxycarbamidum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
CI
Hydroxycarbamid Labatec 500 mg
100
59.44
81.05
10 %
Capsules: Hydroxycarbamidum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
CI
Hydroxycarbamid Labatec 500 mg
30
k.A.
Capsules: Hydroxycarbamidum 500 mg
Labatec Pharma SA
A
FB
G
Irinotecan (L01XX19) 17 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Irinotecan Fresenius 40
mg/2 ml
37.83
57.55
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 100
mg/5 ml
91.81
116.25
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 300
mg/15 ml
245.64
283.55
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 500
mg/25 ml
368.46
416.70
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Labatec 40
mg/2 ml
Durchstechflasche(n)
37.89
57.60
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
Irinotecan Labatec 100
mg/5 ml
Durchstechflasche(n)
91.81
116.25
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
Irinotecan Labatec 300
mg/15 ml
Durchstechflasche(n)
245.64
283.55
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
Irinotecan Labatec 500
mg/25 ml
Durchstechflasche(n)
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500 mg
Labatec Pharma SA
A
FB
G
IP
Irinotecan Orion 40 mg/2 ml
Durchstechflasche(n)
44.51
67.45
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Orion 100 mg/5 ml
Durchstechflasche(n)
107.87
140.25
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Orion 300
mg/15 ml
Durchstechflasche(n)
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Orion 500
mg/25 ml
Durchstechflasche(n)
k.A.
Orion Pharma AG
A
FB
G
IP
Irinotecan Sandoz 40 mg/2 ml
Durchstechflasche(n)
45.07
68.15
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Irinotecan Sandoz 100
mg/5 ml
Durchstechflasche(n)
109.22
141.80
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Irinotecan Sandoz 150
mg/7.5 ml
Durchstechflasche(n)
158.91
198.85
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 150mg / 7.5ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Irinotecan Sandoz 300
mg/15 ml
Durchstechflasche(n)
294.88
354.90
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Irinotecan Sandoz 500
mg/25 ml
Durchstechflasche(n)
k.A.
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
Sandoz
Pharmaceuticals AG
A
FB
G
Arsenic Trioxide (L01XX27) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
Trisenox 12 mg/6 ml
10
3157.85
3450.75
10 %
Concentrate for infusion: Arsenii Trioxidum 12mg / 6ml
Teva Pharma AG
A / SL
FB
G
Anagrelide (L01XX35) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Thromboreductin 0.5 mg
100 Capsule(s)
198.18
230.75
10 %
Capsules: Anagrelidum
OrPha Swiss GmbH
B / SL / SO
FB
G
IP
CI
Xagrid 0,5 mg
100 Capsule(s)
207.67
240.45
10 %
Capsules: Anagrelidum
Takeda Pharma AG
B / SL
FB
G
IP
CI
Thromboreductin 0.5 mg
42 Capsule(s)
94.59
119.70
10 %
Capsules: Anagrelidum
OrPha Swiss GmbH
B / SL / SO
FB
G
IP
CI
Thromboreductin 1 mg
100 Capsule(s)
325.02
367.90
10 %
Capsules: Anagrelidum 1 mg
OrPha Swiss GmbH
B / SL / SO
FB
G
Eribulin (L01XX41) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
Halaven
Durchstechflasche(n)
188.66
221.60
10 %
Injection solution: Eribulini Mesilas 1 mg
Eisai Pharma AG
A / SL
FB
G
Eribulin Advanz Pharma
0.44 mg/ml
k.A.
Injection solution: Eribulinum
Advanz Pharma
Specialty Medicine
Switzerland GmbH
A
FB
G
Aflibercept (L01XX44) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
Zaltrap 100 mg/4 ml
Durchstechflasche(n)
388.94
439.40
10 %
concentré pour solution pour perfusion: Afliberceptum 100mg / 4ml
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
L
IP
Zaltrap 200 mg/8 ml
Durchstechflasche(n)
777.87
862.40
10 %
concentré pour solution pour perfusion: Afliberceptum 200mg / 8ml
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
Cytarabine and Daunorubicin (L01XY01) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
Vyxeos liposomal 44
mg/100 mg
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active Agents
MEDA Pharmaceuticals
Switzerland GmbH
A
FB
G
IP
Vyxeos liposomal 44
mg/100 mg
2
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active Agents
MEDA Pharmaceuticals
Switzerland GmbH
A
FB
G
IP
Vyxeos liposomal 44
mg/100 mg
5
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active Agents
MEDA Pharmaceuticals
Switzerland GmbH
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home